[1] AWMF online (2020): S3-Leitlinie: Peri- und Postmenopause – Diagnostik und Interventionen. In: https://register.awmf.org/assets/guidelines/015-062l_S3_HT_Peri-Postmenopause-Diagnostik-Interventionen_2021-01.pdf
[2] Soares, C.N., Prouty, J., Born, L., Steiner, M. (2005): Treatment of menopause-related mood disturbances. In: CNS Spectr. 2005 Jun;10(6):489-97. doi: 10.1017/s109285290002318x.
[3] Jia, Y., Zhou, Z., Xiang, F., Hu, W., & Cao, X. (2024). Global prevalence of depression in menopausal women: A systematic review and meta-analysis. Journal of affective disorders, 358, 474–482. https://doi.org/10.1016/j.jad.2024.05.051
[4] Hawkins S. S. (2025): Associations Between Menopause and Depression. In: Journal of obstetric, gynecologic, and neonatal nursing: JOGNN, 54(1), 20–31. https://doi.org/10.1016/j.jogn.2024.12.004
[5] Hapke, U., Cohrdes, C., & Nübel, J. (2019, 11. Dezember). Depressive Symptomatik im europäischen Vergleich – Ergebnisse des European Health Interview Survey (EHIS) 2 [Fact Sheet]. Journal of Health Monitoring, 4(4), 62–68. https://doi.org/10.25646/6221
[6] Kulkarni, J., Gurvich, C., Mu, E., Molloy, G., Lovell, S., Mansberg, G., Horton, S., Morton, E., Uppal, T., Cashell, C., de Castella, A., Reisel, D., Dear, L., Weatherburn-Reeves, N., Harris, K., Pietrobon, K., Teagle, K., Kim, B. Y., Newson, L., & Szoeke, C. (2024): Menopause depression: Under recognised and poorly treated. In: The Australian and New Zealand journal of psychiatry, 58(8), 636–640. https://doi.org/10.1177/00048674241253944
[7] Dudenredaktion. (n.d.). Klimakterium. Duden – Deutsches Universalwörterbuch. Retrieved June 23, 2025, from https://www.duden.de/rechtschreibung/Klimakterium
[8] De Liz, Sheila (2020): Woman on fire. Hamburg, Rowohlt Verlag.
[9] Taraborrelli S. (2015). Physiology, production and action of progesterone. Acta obstetricia et gynecologica Scandinavica, 94 Suppl 161, 8–16. https://doi.org/10.1111/aogs.12771
[10] Seifert-Klauss, V. (2015): Neuzeit der Hormon- bzw. Hormonersatztherapie. In: Frauenarzt 56/6.
[11] Santoro, N., Roeca, C., Peters, B.A., Neal-Perry, G. (2021): The Menopause Transition: Signs, Symptoms, and Management Options. In: J Clin Endocrinol Metab. 2021 Jan 1;106(1):1-15. doi: 10.1210/clinem/dgaa764.
[12] Bromberger, J.T., et al. (2011): Mood and menopause: findings from the Study of Women’s Health Across the Nation (SWAN) over 10 years. In: Obstet Gynecol Clin North Am. 38(3):609–25.
[13] Bromberger, J.T., Kravitz, H.M., Chang, Y., Randolph, J.F. Jr, Avis, N.E., Gold, E.B., Matthews, K.A. (2013): Does risk for anxiety increase during the menopausal transition? Study of women’s health across the nation. In: Menopause. 2013 May;20(5):488-95. doi: 10.1097/GME.0b013e3182730599.
[14] Baker F. C. (2023). Optimizing sleep across the menopausal transition. Climacteric : the journal of the International Menopause Society, 26(3), 198–205. https://doi.org/10.1080/13697137.2023.2173569
[15] Borozan, S., Kamrul-Hasan, A. B. M., & Pappachan, J. M. (2024): Hormone replacement therapy for menopausal mood swings and sleep quality: The current evidence. World journal of psychiatry, 14(10), 1605–1610. https://doi.org/10.5498/wjp.v14.i10.1605
[16] Bundesinstitut für Arzneimittel und Medizinprodukte. (o. J.). ICD-10-GM 2025: F30–F39 Affektive Störungen. In Klassifikationen – ICD-10-GM Kode-Suche https://klassifikationen.bfarm.de/icd-10-gm/kode-suche/htmlgm2025/block-f30-f39.htm
[17] Dobrek, L., & Głowacka, K. (2023): Depression and Its Phytopharmacotherapy – A Narrative Review. In: International journal of molecular sciences, 24(5), 4772. https://doi.org/10.3390/ijms24054772
[18] Lialy, H. E., Mohamed, M. A., AbdAllatif, L. A., Khalid, M., & Elhelbawy, A. (2023): Effects of different physiotherapy modalities on insomnia and depression in perimenopausal, menopausal, and post-menopausal women: a systematic review. In: BMC women’s health, 23(1), 363. https://doi.org/10.1186/s12905-023-02515-9
[19] Kris-Etherton, P. M., Petersen, K. S., Hibbeln, J. R., Hurley, D., Kolick, V., Peoples, S., Rodriguez, N., & Woodward-Lopez, G. (2021): Nutrition and behavioral health disorders: depression and anxiety. Nutrition reviews, 79(3), 247–260. https://doi.org/10.1093/nutrit/nuaa025
[20] Maki, P. M., Kornstein, S. G., Joffe, H., Bromberger, J. T., Freeman, E. W., Athappilly, G., Bobo, W. V., Rubin, L. H., Koleva, H. K., Cohen, L. S., & Soares, C. N. (2019): Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations. Journal of women’s health (2002), 28(2), 117–134. https://doi.org/10.1089/jwh.2018.27099.mensocrec
[21] Mejia-Gomez, J., Phung, N., Philippopoulos, E., Murphy, K. E., & Wolfman, W. (2021): The impact of cannabis use on vasomotor symptoms, mood, insomnia and sexuality in perimenopausal and postmenopausal women: a systematic review. In: Climacteric: the journal of the International Menopause Society, 24(6), 572–576. https://doi.org/10.1080/13697137.2021.1898581
[22] Dahlgren, M. K., El-Abboud, C., Lambros, A. M., Sagar, K. A., Smith, R. T., & Gruber, S. A. (2022): A survey of medical cannabis use during perimenopause and postmenopause. Menopause (New York, N.Y.), 29(9), 1028–1036. https://doi.org/10.1097/GME.0000000000002018
[23] Herson, M., & Kulkarni, J. (2022): Hormonal Agents for the Treatment of Depression Associated with the Menopause. Drugs & aging, 39(8), 607–618. https://doi.org/10.1007/s40266-022-00962-x